295 related articles for article (PubMed ID: 33158864)
1. The 3.2-Å resolution structure of human mTORC2.
Scaiola A; Mangia F; Imseng S; Boehringer D; Berneiser K; Shimobayashi M; Stuttfeld E; Hall MN; Ban N; Maier T
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33158864
[TBL] [Abstract][Full Text] [Related]
2. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
3. Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt.
Yu Z; Chen J; Takagi E; Wang F; Saha B; Liu X; Joubert LM; Gleason CE; Jin M; Li C; Nowotny C; Agard D; Cheng Y; Pearce D
J Biol Chem; 2022 Sep; 298(9):102288. PubMed ID: 35926713
[TBL] [Abstract][Full Text] [Related]
4. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
García-Martínez JM; Alessi DR
Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
[TBL] [Abstract][Full Text] [Related]
5. Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
Benavides-Serrato A; Lee J; Holmes B; Landon KA; Bashir T; Jung ME; Lichtenstein A; Gera J
PLoS One; 2017; 12(4):e0176599. PubMed ID: 28453552
[TBL] [Abstract][Full Text] [Related]
6. Identification of rictor as a novel substrate of Polo-like kinase 1.
Shao T; Liu X
Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
[TBL] [Abstract][Full Text] [Related]
7. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.
Lamming DW; Mihaylova MM; Katajisto P; Baar EL; Yilmaz OH; Hutchins A; Gultekin Y; Gaither R; Sabatini DM
Aging Cell; 2014 Oct; 13(5):911-7. PubMed ID: 25059582
[TBL] [Abstract][Full Text] [Related]
8. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
9. Identification of Protor as a novel Rictor-binding component of mTOR complex-2.
Pearce LR; Huang X; Boudeau J; Pawłowski R; Wullschleger S; Deak M; Ibrahim AF; Gourlay R; Magnuson MA; Alessi DR
Biochem J; 2007 Aug; 405(3):513-22. PubMed ID: 17461779
[TBL] [Abstract][Full Text] [Related]
10. The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.
Yoon MS
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29077002
[TBL] [Abstract][Full Text] [Related]
11. mTORC2 Suppresses GSK3-Dependent Snail Degradation to Positively Regulate Cancer Cell Invasion and Metastasis.
Zhang S; Qian G; Zhang QQ; Yao Y; Wang D; Chen ZG; Wang LJ; Chen M; Sun SY
Cancer Res; 2019 Jul; 79(14):3725-3736. PubMed ID: 31142514
[TBL] [Abstract][Full Text] [Related]
12. Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein.
Glidden EJ; Gray LG; Vemuru S; Li D; Harris TE; Mayo MW
J Biol Chem; 2012 Jan; 287(1):581-588. PubMed ID: 22084251
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA
Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.
Damerill I; Biggar KK; Abu Shehab M; Li SS; Jansson T; Gupta MB
Mol Endocrinol; 2016 Feb; 30(2):201-16. PubMed ID: 26714229
[TBL] [Abstract][Full Text] [Related]
15. Cryo-EM structure of human mTOR complex 2.
Chen X; Liu M; Tian Y; Li J; Qi Y; Zhao D; Wu Z; Huang M; Wong CCL; Wang HW; Wang J; Yang H; Xu Y
Cell Res; 2018 May; 28(5):518-528. PubMed ID: 29567957
[TBL] [Abstract][Full Text] [Related]
16. Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Implications for Cardiometabolic Disease.
Shi F; Collins S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511253
[TBL] [Abstract][Full Text] [Related]
17. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
Zou Z; Chen J; Yang J; Bai X
Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881
[TBL] [Abstract][Full Text] [Related]
18. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
19. mTORC2/RICTOR exerts differential levels of metabolic control in human embryonic, mesenchymal and neural stem cells.
Chu Q; Liu F; He Y; Jiang X; Cai Y; Wu Z; Yan K; Geng L; Zhang Y; Feng H; Zhou K; Wang S; Zhang W; Liu GH; Ma S; Qu J; Song M
Protein Cell; 2022 Sep; 13(9):676-682. PubMed ID: 35038130
[No Abstract] [Full Text] [Related]
20. Rictor regulates cell migration by suppressing RhoGDI2.
Agarwal NK; Chen CH; Cho H; Boulbès DR; Spooner E; Sarbassov DD
Oncogene; 2013 May; 32(20):2521-6. PubMed ID: 22777355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]